Breaking barriers: patient-derived xenograft (PDX) models in lung cancer drug development-are we close to the finish line?

被引:0
|
作者
Karim, Nagla Abdel [1 ,2 ]
Zaza, Mohamed [3 ]
Subramanian, Janakiraman [1 ,2 ]
机构
[1] Inova Schar Canc Inst, Dept Oncol, 8081 Innovat Pkwy Dr, Fairfax, VA 22031 USA
[2] Univ Virginia, Med Ctr, Dept Med, Charlottesville, VA 22904 USA
[3] Cairo Univ, NCI, Dept Radiat Oncol & Nucl Med, Cairo, Egypt
关键词
Patient-derived xenograft models in lung cancer (PDX models in lung cancer); MET; epidermal growth factor receptor (EGFR); capmatinib; osimertinib; SAVOLITINIB PLUS OSIMERTINIB; NSCLC;
D O I
10.21037/tlcr-24-206
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2098 / 2102
页数:5
相关论文
共 50 条
  • [21] Development of a Patient-Derived Xenograft (PDX) of Breast Cancer Bone Metastasis in a Zebrafish Model
    Mercatali, Laura
    La Manna, Federico
    Groenewoud, Arwin
    Casadei, Roberto
    Recine, Federica
    Miserocchi, Giacomo
    Pieri, Federica
    Liverani, Chiara
    Bongiovanni, Alberto
    Spadazzi, Chiara
    de Vita, Alessandro
    van der Pluijm, Gabri
    Giorgini, Andrea
    Biagini, Roberto
    Amadori, Dino
    Ibrahim, Toni
    Snaar-Jagalska, Ewa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (08):
  • [22] Development of patient-derived xenograft (PDX) models for gastrointestinal stromal tumors (GIST) as a pre-clinical platform for drug development
    Ricono, Jill
    Mullins, Chelsea
    Nair, Praveen
    Mirsaidi, Cyrus
    Broudy, Thomas
    CANCER RESEARCH, 2015, 75
  • [23] Utilization of Patient-derived xenograft models in drug discovery and development research
    Yagishita, Shigehiro
    CANCER SCIENCE, 2024, 115 : 742 - 742
  • [24] Patient-derived xenograft (PDX) models for peritoneal metastasis of colorectal cancer as novel platform for drug testing and biomarker identification
    Walther, Wolfgang
    Pachmayr, Eva
    Brzezicha, Bernadette
    Buettner, Britta
    Hoffmann, Jens
    Rau, Beate
    Stein, Ulrike
    CLINICAL & EXPERIMENTAL METASTASIS, 2017, 34 (08) : 524 - 524
  • [25] Patient-Derived Xenograft Models in Cancer Research
    van Weerden, Wytske M.
    CANCERS, 2021, 13 (04)
  • [26] Patient-derived xenograft models in hepatopancreatobiliary cancer
    Binhua Pan
    Xuyong Wei
    Xiao Xu
    Cancer Cell International, 22
  • [27] Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models
    Prasetyanti, Pramudita R.
    van Hooff, Ander R.
    van Herwaarden, Tessa
    de Vries, Nathalie
    Kalloe, Kieshen
    Rodermond, Hans
    van Leersum, Ronald
    de Jong, Joan H.
    Franitza, Marek
    Nuernberg, Peter
    Todaro, Matilde
    Stassi, Giorgio
    Medema, Jan Paul
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (02) : 366 - 371
  • [28] Preclinical evaluation of novel treatment strategies in patient-derived xenograft (PDX) models of pancreatic cancer
    Behrens, Diana
    Buettner, Britta
    Lawlor, Rita L.
    Heeschen, Christopher
    Buchholz, Malte
    Siveke, Jens
    Wengner, Antje M.
    Saluja, Ashok
    Hoffmann, Jens
    CANCER RESEARCH, 2018, 78 (13)
  • [29] Preclinical evaluation of novel treatment strategies in patient-derived xenograft (PDX) models of pancreatic cancer
    Behrens, D.
    Lawlor, R. T.
    Heeschen, C.
    Buchholz, M.
    Siveke, J.
    Wengner, A.
    Saluja, A.
    Buettner, B.
    Hoffmann, J.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E101 - E101
  • [30] Stability and preclinical efficacy of patient-derived xenograft (PDX) models in endometrial cancer and uterine sarcoma
    Jeong, S. Y.
    Kang, J. H.
    Kim, M. S.
    Paik, E. S.
    Lee, Y. Y.
    Choi, C. H.
    Kim, T. J.
    Kim, B. G.
    Bae, D. S.
    Lee, J. W.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 120 - 120